Role and possible mechanism of pseudogene FMO6P in inhibiting invasion and metastasis of gastric cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 2
Abstract
[Objective] To determine the expression and clinical significance of pseudogene FMO6P in gastric cancer, and explore its functions and underlying molecular mechanism in regulating the invasion and metastasis of gastric cancer cells. [Methods] The expression level of FMO6P in gastric cancer tissues and cell lines was detected by quantitative real time polymerase chain reaction(qRT-PCR). The migration and invasion abilities of gastric cancer cells were detected by transwell assay. The effect of FMO6P on the tumor formation and peritoneal dissemination of gastric cancer cells were evaluated by injecting FMO6P-overexpressing gastric cancer cells into the subcutaneous or peritoneal cavity of nude mice respectively. The expression levels of epithelial-mesenchymal transition(EMT) markers, including E-cadherin, N-cadherin, ZEB1, MMP2, and the activation of AKT/mTOR pathway in FMO6P-overexpressing or knockdown gastric cancer cells were measured by Western blot. [Results] The expression of FMO6P was significantly reduced in tumor tissues compared to its adjacent non-tumor tissues of gastric cancer, FMO6P expression level in tumor tissues was correlated with tumor size and TNM stage. Overexpression of FMO6P significantly inhibited the invasion and migration abilities of gastric cancer cells, while downregulation of FMO6P expression promoted the invasion and migration ability of gastric cancer cells. Overexpression of FMO6P in gastric cancer cells significantly inhibited the subcutaneous tumor formation and peritoneal dissemination of gastric cancer cells in nude mice. Moreover, overexpression of FMO6P promoted the expression of E-cadherin, and inhibited the expression of N-cadherin, ZEB1, and MMP2 in gastric cancer cells. The phosphorylation levels of AKT and mTOR were also downregulated in gastric cancer cells overexpressing FMO6P. [Conclusion] All these findings suggested that pseudogene FMO6P suppresses the invasion and migration potential of gastric cancer cells in vitro and in vivo, which is possibly through the inhibition of the AKT/mTOR signaling pathway.
Authors and Affiliations
Xiongyan WU, Zhen LI, Zhenjia YU, liping SU
Keywords
Related Articles
- EP ID EP750957
- DOI 10.16139/j.1007-9610.2024.02.12
- Views 47
- Downloads 1
Development and prospect of laparoscopic living donor hepatectomy
In recent years, benifit by the advancement of minimally invasive surgical techniques, laparoscopic living donor hepatectomy（LLDH） has experienced rapid development. Since this technology was first reported in 2002, ma...
Diagnostic application of SpyGlass in indeterminate stricture of hilar bile duct
[Objective:] To investigate the diagnostic value of SpyGlass choledochoscopy system in indeterminate stricture of hilar bile duct. [Methods:] A retrospective analysis was conducted on 146 patients with indeterminate stri...
Current status and prospect of endoscopic photodynamic therapy for unresectable extrahepatic cholangiocarcinoma and ampullary carcinoma
Unresectable extrahepatic cholangiocarcinoma and ampullary carcinoma have high malignant degree and poor prognosis. At present, internal or external biliary drainage is the main palliative treatment, which can improve pa...
Mechanism, clinical manifestations, prevention, and treatment of air embolism during ERCP
Endoscopic retrograde cholangiopancreatography (ERCP) is a pivotal endoscopic technique for hepatobiliary and pancreatic diseases. Although rare, air embolism during ERCP carries a high risk of mortality and disability,...
Combination of targeted multikinase inhibitor and radioiodine: a new strategy of treatment for advanced differentiated thyroid carcinoma
Advanced differentiated thyroid carcinoma (ADTC) lacks effective treatment options, and has a poor prognosis, which is an urgent clinical problem to be resolved. Targeted multikinase inhibitor(MKI) has been approved for...